Multi-Collagen Strengthening Cream for Wrinkle Reduction Day and Night 50+, 50 ml
Dermika Luxury Neocollagen is a breakthrough cosmetics based on ingredients that rebuild up to 5 types of collagen to improve your skin's density. We've included a collagen reconstructor – an isolate from nanoplankton, a natural phenomenon dating back 2 million years. As a result of 10 years of research on this marine organism, we managed to obtain an ingredient that reduces the effects of slower cellular metabolism, such as skin laxity and loss of firmness. In the formula of this strengthening cream, we combined nanoplankton isolate with the Skin Correct complex and multiactive peptides to restore skin firmness and smoothness, reduce wrinkles, and improve the microrelief of the epidermis. The cream's effectiveness is ensured by carefully selected and luxurious active ingredients: Collagen Reconstructor (nanoplankton isolate) - stimulates the synthesis of structural collagen types I, III, IV, and VII, so your skin regains density and firmness. 3 multiactive rejuvenating peptides - advanced peptides that perfectly penetrate the epidermis, stimulate the synthesis of collagen types I, III, IV, VII, and XVII. They effectively combat the effects of aging, reducing wrinkles and smoothing the skin. The Skin Correct complex is a composition of active ingredients of natural origin. It regulates sebum secretion and reduces the size of skin pores, leaving the skin well-groomed and naturally beautiful. Squalane 3.5% prevents water loss from the epidermis and restores softness to mature skin. The cream's effectiveness is confirmed by research. Collagen Strengthening Cream 50+, a unique composition of active ingredients, makes the skin smoother and softer to the touch, firmer and more elastic. After just 4 weeks of use, the cream provides: Improved skin firmness and elasticity* 95% Improved skin tone* 95% Visible reduction of skin roughness* 85% Reduced wrinkles** 75% Stimulates collagen synthesis I*** +127%* Satisfaction rating after 4 weeks of use, group of 20 women aged 50-59.** Percentage of test subjects in whom the effect was confirmed in instrumental tests after 4 weeks of use.*** In vitro tests.
Comment